InvestorsHub Logo
icon url

williamssc

07/18/17 9:57 PM

#111685 RE: plexrec #111683

I agree Missling needs to update shareholders on at a minimum the open label extension progress. But for reasons only Missling knows he chooses not too, so I believe there is importance to that. Just have to trust the CEO at this point.
icon url

blueyedcatch

07/18/17 10:13 PM

#111689 RE: plexrec #111683

After reading the first line of your post it seemed like you were going to reinforce the positives that we all own the stock for,but then you faded quickly into nothing of the sort. Hard to tell where you stand after reading the whole post. My great Grandmothers favorite saying was,, Good things come to those who wait.. I`d say that the company has a lot riding on the trial and it`s design,so as to have the best odds for an approval. IMO,that`s why the recent FDA hire,with someone with so many years of experience in trial designs at the FDA. The Dr. knows what`s at stake,is executing his plan,and keeping it quiet until everything is done.We can only hope for everyone`s sake,especially the little girls with Retts,that the new FDA hire gets the trial design done and approved by the FDA faster than expected,prior to his hire,and we`re all pleasantly surprised,but again there`s a ton riding on getting Retts done right,and then approved.It opens the door up for AA on all the other Applications,and will certainly bring the spot light upon little old Anavex.